• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Arch Microbiol . Neuropathogenesis of SARS-CoV-2 in human neuronal, microglial and glial cells

tetano

Editor, Senior Moderator
Arch Microbiol


. 2024 Jul 8;206(8):345.
doi: 10.1007/s00203-024-04075-4. Neuropathogenesis of SARS-CoV-2 in human neuronal, microglial and glial cells

Narendra Kumar[SUP] 1 [/SUP], Rashmi Santhoshkumar[SUP] 2 [/SUP], Ragini Agrawal[SUP] 3 [/SUP], Amit Singh[SUP] 3 [/SUP], Vijayalakshmi Kalyan[SUP] 4 [/SUP], Anita Desai[SUP] 1 [/SUP], Vasanthapuram Ravi[SUP] 1 [/SUP], Manjunatha M Venkataswamy[SUP] 5 [/SUP]



Affiliations
Abstract

Neurological complications, both acute and chronic, are reported commonly in COVID-19 affected individuals. In this context, the understanding of pathogenesis of SARS-CoV-2 in specific cells of central nervous system (CNS) origin is relevant. The present study explores infection biology of a clinical isolate of SARS-CoV-2 in human cell lines of neural origin such as the glioblastoma (U87-MG), neuroblastoma (SHSY5Y) and microglia (C20). Despite showing clear evidence of infection by immunofluorescence with an anti-spike protein antibody, all the three neural cell lines were observed to be highly restrictive to the replication of the infecting virus. While the U87-MG glioblastoma cells demonstrated no cytopathic effects and a low viral titre with no signs of replication, the SHSY5Y neuroblastoma cells exhibited cytopathic effects with bleb formation but no evidence of viable virus. The C20 microglial cells showed neither signs of cytopathic effects nor viable virus. Ultrastructural studies demonstrated intracellular virions in infected neural cells. The presence of lipid droplets in infected SHSY5Y cells suggested an impact on host cell metabolism. The decrease in viral RNA levels over time in all the neural cell lines suggested restricted viral replication. In conclusion, this study highlights the limited susceptibility of neural cells to SARS-CoV-2 infection. This reduced permissibility of neural cell lines to SARS-CoV-2 may point to their inherent lower expression of receptors that support viral entry in addition to the intracellular factors that potently inhibit viral replication. The study findings prompt further investigation into the mechanisms of SARS-CoV-2 infection of neural cells.

Keywords: COVID-19; Genomics; Neuropathogenesis; Neurotropism; SARS-CoV-2; Ultrastructure.

 
Back
Top Bottom